In pre-clinical testing, multiple proprietary molecules “showed consistent positive results when compared to the parent molecule”.

As investors become increasingly concerned about hedging their portfolios, there are few safe alternatives. Psychedelic stocks are a sane choice for a crazy world.

MindMed officially announces its inclusion in the FTSE Russell 3000.

Psyched Wellness announces its latest pre-clinical study on AME-1.

Analysts Jason McCarthy and Michael Okunewitch of Maxim Group have initiated coverage of Mind Cure Health.

Clarence Thomas, one of the Supreme Court’s most conservative justices, said Monday that because of the hodgepodge of federal policies on marijuana, federal laws against its use or cultivation may no longer make sense.

Harvard Law School on Wednesday announced the launch of a first-of-its-kind psychedelics policy center that it hopes will inform legislation and help clinicians navigate this burgeoning medical space as reform continues to advance.

Cybin Inc releases its full-year financial results for the fiscal year ended March 31, 2021 and provides business highlights.

The use of mescaline, a psychedelic substance derived from the peyote cactus, appears to be associated with improvements in depression and anxiety, according to a new preliminary study published in the journal ACS Pharmacology & Translational Science.

As the Mental Health Pandemic spirals out of control, we see a positive sign: the mainstream media has finally noticed it.